205 related articles for article (PubMed ID: 30479569)
1. Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors.
Ren Y; Tao C; Wang X; Ju Y
Cancer Cell Int; 2018; 18():190. PubMed ID: 30479569
[TBL] [Abstract][Full Text] [Related]
2. Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes.
Birks DK; Donson AM; Patel PR; Sufit A; Algar EM; Dunham C; Kleinschmidt-DeMasters BK; Handler MH; Vibhakar R; Foreman NK
Pediatr Blood Cancer; 2013 Jul; 60(7):1095-102. PubMed ID: 23382118
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
4. Rhabdoid tumors in patients conceived following ART: is there an association?
Nemes K; Benesch M; Kolarova J; Johann P; Hasselblatt M; Thomas C; Bens S; Glaser S; Ammerpohl O; Liaugaudiene O; Sadeghipour A; von der Weid N; Schmid I; Gidding C; Erdreich-Epstein A; Khurana C; Ebetsberger-Dachs G; Lemmer A; Khatib Z; Hernández Marqués C; Pears J; Quehenberger F; Kordes U; Vokuhl C; Gerss J; Schwarz H; Bison B; Biegel JA; Siebert R; Frühwald MC
Hum Reprod; 2023 Oct; 38(10):2028-2038. PubMed ID: 37553222
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Signature and Potential Target Genes of Six Long Non-coding RNA in Laryngeal Squamous Cell Carcinoma.
Gong S; Xu M; Zhang Y; Shan Y; Zhang H
Front Genet; 2020; 11():413. PubMed ID: 32411183
[TBL] [Abstract][Full Text] [Related]
7. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.
Bhattacharjee M; Hicks J; Langford L; Dauser R; Strother D; Chintagumpala M; Horowitz M; Cooley L; Vogel H
Ultrastruct Pathol; 1997; 21(4):369-78. PubMed ID: 9206002
[TBL] [Abstract][Full Text] [Related]
9. Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors.
Antonelli M; Hasselblatt M; Haberler C; Di Giannatale A; Garrè ML; Donofrio V; Lauriola L; Ridola V; Arcella A; Frühwald M; Giangaspero F
Brain Pathol; 2011 Sep; 21(5):558-63. PubMed ID: 21261775
[TBL] [Abstract][Full Text] [Related]
10. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
[TBL] [Abstract][Full Text] [Related]
11. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement.
Miller KE; Wheeler G; LaHaye S; Schieffer KM; Cearlock S; Venkata LPR; Bravo AO; Grischow OE; Kelly BJ; White P; Pierson CR; Boué DR; Koo SC; Klawinski D; Ranalli MA; Shaikhouni A; Salloum R; Shatara M; Leonard JR; Wilson RK; Cottrell CE; Mardis ER; Koboldt DC
Front Oncol; 2022; 12():932337. PubMed ID: 35912263
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
13. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.
Ravindra N; Rao S; Arivazhagan A; Santosh V
Childs Nerv Syst; 2021 Dec; 37(12):3769-3775. PubMed ID: 34611764
[TBL] [Abstract][Full Text] [Related]
14. Adult Atypical Teratoid/Rhabdoid Tumors.
Wu WW; Bi WL; Kang YJ; Ramkissoon SH; Prasad S; Shih HA; Reardon DA; Dunn IF
World Neurosurg; 2016 Jan; 85():197-204. PubMed ID: 26344637
[TBL] [Abstract][Full Text] [Related]
15. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors.
Birks DK; Kleinschmidt-DeMasters BK; Donson AM; Barton VN; McNatt SA; Foreman NK; Handler MH
Brain Pathol; 2010 Jan; 20(1):140-50. PubMed ID: 19220299
[TBL] [Abstract][Full Text] [Related]
16. Two Cases of Atypical Teratoid/Rhabdoid Tumor in the Spinal Cord: Loss of SMARCB1 in a Child and Loss of SMARCA4 in an Adult.
Morisako T; Umebayashi D; Nagai T; Yamanaka T; Hirose T; Shishido-Hara Y; Konishi E; Hashimoto N
NMC Case Rep J; 2024; 11():27-32. PubMed ID: 38410173
[TBL] [Abstract][Full Text] [Related]
17. Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China.
Wang RF; Guan WB; Yan Y; Jiang B; Ma J; Jiang MW; Wang LF
Pathology; 2016 Oct; 48(6):555-63. PubMed ID: 27558890
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis.
Ma HI; Kao CL; Lee YY; Chiou GY; Tai LK; Lu KH; Huang CS; Chen YW; Chiou SH; Cheng IC; Wong TT
Childs Nerv Syst; 2010 Mar; 26(3):293-303. PubMed ID: 19902219
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
20. CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors.
Nobusawa S; Nakata S; Nakano Y; Kawamura A; Yoshida M; Tamura A; Hasegawa D; Kosaka Y; Ito I; Watanabe R; Oishi T; Hayashi N; Ishikawa E; Sakamoto N; Okura N; Murakami C; Ichimura K; Hirato J; Yokoo H
Am J Surg Pathol; 2020 Nov; 44(11):1459-1468. PubMed ID: 33045149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
